Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Vivos Inc. D/B/A Advanced Medical Isotope Corporation has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are split between 2 distinct examiners within 1 distinct art unit. Robert S Cabral is the busiest examiner, overseeing 1 pending office action. The workload is distributed evenly between the examiners, with each managing one of the pending matters for the company.
Since both examiners are in the same art unit, the company can expect a consistent technical review environment even while dealing with two different individuals. This concentration in 1 art unit for both pending matters allows for a more unified prosecution strategy within the Medical Devices & Mechanical Engineering sector. Practitioners should coordinate their responses to ensure that the technical arguments presented to Robert S Cabral and the other examiner align with the overarching policies of their shared department.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CABRAL, ROBERT S | 1 | 62.6% | +32.5% |
| MOORE, DEVON TYLEN | 1 | 48.9% | +35.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18974143 | RADIOTHERAPY GEL AND METHOD OF PREPARING THE SAME | CABRAL, ROBERT S | — |
| 18401421 | CHILLER FOR USE IN MEDICAL APPLICATIONS | MOORE, DEVON TYLEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18974143 | RADIOTHERAPY GEL AND METHOD OF PREPARING THE SAME | CABRAL, ROBERT S | — |
| 18401421 | CHILLER FOR USE IN MEDICAL APPLICATIONS | MOORE, DEVON TYLEN | — |
| Art Unit | Apps |
|---|---|
| 3763 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18974143 | RADIOTHERAPY GEL AND METHOD OF PREPARING THE SAME | CABRAL, ROBERT S | — | §101§102§103DP | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18401421 | CHILLER FOR USE IN MEDICAL APPLICATIONS | MOORE, DEVON TYLEN | 3763 | §103§112 | Final Rejection | — | Pending | Dec 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial